SCHEMBL7308008

SCHEMBL7308008

CCOC(=O)N(CCCCN1CC=C(c2ccccc2)CC1)c1cccc(C)c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.42
PARP1 P09874 1/20 0.42
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HTR7 P34969 4/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
HTR1A P08908 2/20 0.40
DRD4 P21917 2/20 0.40
ALOX15 P16050 1/20 0.40
APEX1 P27695 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DRD3 P35462 1/20 0.39
HTR2A P28223 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7297468 0.92 DRD3 (0.41) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7310638 0.91 KDM4E (0.43) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7307713 0.91 HTR7 (0.44) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7303017 0.88 SIGMAR1 (0.39) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7307166 0.87 KDM4E (0.43) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7301503 0.85 HTR7 (0.43) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7359856 0.85 KDM4E (0.44) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7302447 0.85 PARP1 (0.42) SIGMAR1PARP1KDM4ETDP1ALDH1A1
SCHEMBL7310797 0.83 DRD3 (0.38) SIGMAR1KDM4ETDP1ALDH1A1MAPT
SCHEMBL7299099 0.82 HTR1A (0.48) SIGMAR1PARP1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed